Loading...
Please wait, while we are loading the content...
Summary of the American Heart Association's evidence-based guidelines for cardiovascular disease prevention in women.
| Content Provider | Semantic Scholar |
|---|---|
| Author | Mosca, Lori J. Appel, Lawrence J. Benjamin, Emelia J. Berra, Kathy A. Chandra-Strobos, Nisha Fabumni, Rosalind P. Grady, Deborah Haan, Constance K. Hayes, Sharonne N. Judelson, Debra R. Keenan, Nora L. McBride, Patrick Oparil, Suzanne Ouyang, Pamela Oz, Mehmet C. Mendelsohn, Michael E. Pasternak, Richard C. Pinn, Vivian W. Robertson, Rose Marie Schenck-Gustafsson, Karin Sila, Cathy A. Smith, Sidney C. Sopko, George Taylor, Anne L. Walsh, Brian W. Wenger, Nanette K. Williams, Christine Lisa |
| Copyright Year | 2004 |
| Abstract | Cardiovascular disease (CVD) is the largest killer of women in the United States.1 More than 500 000 women die of CVD annually, more than the number of CVD-related deaths in men or related to the next 7 causes of death in women combined.1 Despite these statistics, a national survey in 2003 by the American Heart Association (AHA) showed that less than half of all women know that CVD is their leading cause of death.2 In an effort to raise awareness and educate health care providers and the public about methods to prevent incident and recurrent CVD events, an expert panel was convened to establish evidence-based guidelines for the prevention of CVD in women. The panel consisted of representatives from 11 AHA Scientific Councils and 11 federal and other professional organizations. There were an additional 22 endorsers. Details of the process and the complete guidelines have been published.3 See page e29 Briefly, candidate recommendations for CVD risk-reducing interventions were discussed, prioritized, and then selected for a systematic literature search. Randomized, clinical trials and large, prospective, cohort studies evaluating cardiovascular risk-reducing interventions with a focus on major clinical endpoints (death, myocardial infarction [MI], stroke, revascularization procedure, congestive heart failure, or a composite CVD endpoint), whether or not there were female participants, were included. Nearly 7000 abstracts were identified in the initial search; 1279 were included for full-text screening and 399 studies were included in the summary evidence tables for each recommendation, with sex-specific information if available. The evidence tables are published online at http://atvb.ahajournals.org. The expert panel used an evidence rating system based on methods used in previous AHA/American College of Cardiology (ACC) guidelines and is outlined in Table 1.4 In addition, a generalizability index was used to rate the likelihood that results generated from studies … |
| File Format | PDF HTM / HTML |
| DOI | 10.1161/01.ATV.0000121481.56512.c6 |
| PubMed reference number | 15003972 |
| Journal | Medline |
| Volume Number | 24 |
| Issue Number | 3 |
| Alternate Webpage(s) | http://www.columbia.edu/itc/hs/medical/clerkships/primcare/case/hypertension/library/WomenHTN.pdf |
| Alternate Webpage(s) | https://doi.org/10.1161/01.ATV.0000121481.56512.c6 |
| Journal | Arteriosclerosis, thrombosis, and vascular biology |
| Language | English |
| Access Restriction | Open |
| Content Type | Text |
| Resource Type | Article |
